Disease The normal bone marrow architecture can be damaged or displaced by
aplastic anemia,
malignancies such as
multiple myeloma, or infections such as
tuberculosis, leading to a decrease in the production of blood cells and blood platelets. The bone marrow can also be affected by various forms of
leukemia, which attacks its hematologic progenitor cells. Furthermore, exposure to
radiation or
chemotherapy will kill many of the rapidly dividing cells of the bone marrow, and will therefore result in a depressed
immune system. Many of the symptoms of
radiation poisoning are due to damage sustained by the bone marrow cells. To diagnose diseases involving the bone marrow, a
bone marrow aspiration is sometimes performed. This typically involves using a hollow needle to acquire a sample of red bone marrow from the
crest of the ilium under general or
local anesthesia.
CT imaging has somewhat better capacity for assessing the marrow cavity of bones, although with low sensitivity and specificity. For example, normal fatty "yellow" marrow in adult long bones is of low density (-30 to -100 Hounsfield units), between subcutaneous fat and soft tissue. Tissue with increased cellular composition, such as normal "red" marrow or cancer cells within the medullary cavity will measure variably higher in density.
MRI is more sensitive and specific for assessing bone composition. MRI enables assessment of the average molecular composition of soft tissues and thus provides information regarding the relative fat content of marrow. In adult humans, "yellow" fatty marrow is the dominant tissue in bones, particularly in the (peripheral)
appendicular skeleton. Because fat molecules have a high
T1-relaxivity, T1-weighted imaging sequences show "yellow" fatty marrow as bright (hyperintense). Furthermore, normal fatty marrow loses signal on fat-saturation sequences, in a similar pattern to subcutaneous fat. When "yellow" fatty marrow becomes replaced by tissue with more cellular composition, this change is apparent as decreased brightness on T1-weighted sequences. Both normal "red" marrow and pathologic marrow lesions (such as cancer) are darker than "yellow" marrow on T1-weight sequences, although can often be distinguished by comparison with the MR signal intensity of adjacent soft tissues. Normal "red" marrow is typically equivalent or brighter than skeletal muscle or intervertebral disc on T1-weighted sequences. Fatty marrow change, the inverse of red marrow
hyperplasia, can occur with normal aging, though it can also be seen with certain treatments such as
radiation therapy. Diffuse marrow T1 hypointensity without contrast enhancement or cortical discontinuity suggests red marrow conversion or
myelofibrosis. Falsely normal marrow on T1 can be seen with diffuse
multiple myeloma or
leukemic infiltration when the water to fat ratio is not sufficiently altered, as may be seen with lower grade tumors or earlier in the disease process.
Histology ed bone marrow aspirate smear from a patient with
leukemia Bone marrow examination is the pathologic analysis of samples of bone marrow obtained via
biopsy and bone marrow aspiration. Bone marrow examination is used in the diagnosis of a number of conditions, including leukemia, multiple myeloma,
anemia, and
pancytopenia. The bone marrow produces the cellular elements of the blood, including
platelets,
red blood cells and
white blood cells. While much information can be gleaned by testing the blood itself (drawn from a vein by
phlebotomy), it is sometimes necessary to examine the source of the blood cells in the bone marrow to obtain more information on hematopoiesis; this is the role of bone marrow aspiration and biopsy. The ratio between
myeloid series and
erythroid cells is relevant to bone marrow function, and also to diseases of the bone marrow and
peripheral blood, such as leukemia and anemia. The normal myeloid-to-erythroid ratio is around 3:1; this ratio may increase in
myelogenous leukemias, decrease in
polycythemias, and reverse in cases of
thalassemia.
Donation and transplantation In a
bone marrow transplant, hematopoietic stem cells are removed from a person and infused into another person (
allogeneic) or into the same person at a later time (
autologous). If the donor and recipient are compatible, these infused cells will then travel to the bone marrow and initiate blood cell production. Transplantation from one person to another is conducted for the treatment of severe bone marrow diseases, such as congenital defects, autoimmune diseases or malignancies. The patient's own marrow is first killed off with drugs or
radiation, and then the new stem cells are introduced. Before radiation therapy or
chemotherapy in cases of
cancer, some of the patient's hematopoietic stem cells are sometimes harvested and later infused back when the therapy is finished to restore the immune system. Bone marrow stem cells can be induced to become neural cells to treat neurological illnesses, and can also potentially be used for the treatment of other illnesses, such as
inflammatory bowel disease. In 2013, following a clinical trial, scientists proposed that bone marrow transplantation could be used to treat
HIV in conjunction with
antiretroviral drugs; however, it was later found that HIV remained in the bodies of the test subjects.
Harvesting The stem cells are typically harvested directly from the red marrow in the
iliac crest, often under
general anesthesia. The procedure is minimally invasive and does not require stitches afterwards. Depending on the donor's health and reaction to the procedure, the actual harvesting can be an
outpatient procedure, or can require 1–2 days of recovery in the hospital. Another option is to administer certain drugs that stimulate the release of stem cells from the bone marrow into circulating blood. An
intravenous catheter is inserted into the donor's arm, and the stem cells are then filtered out of the blood. This procedure is similar to that used in blood or platelet donation. In adults, bone marrow may also be taken from the
sternum, while the
tibia is often used when taking samples from infants. In newborns, stem cells may be retrieved from the
umbilical cord.
Fertility aid One of the most damaged areas of the body following chemotherapy is typically the uterus. Following uterine damage due to cancer treatment, follicle damage makes it difficult for individuals to get pregnant even if viable ova are present. With bone marrow stem cell transplants, chemotherapy patients have been able to increase their fertility as follicle damage is repaired. As follicles are necessary for ovum attachment to the
endometrium, it is important for these areas to be repaired in order to increase fertility. For individuals who have sustained egg and follicle damage, IVF has been found to be more effective following bone marrow stem cell transplantation. One human clinical case has shown improvements of uterine lining thickness and overall endometrium repair following bone marrow stem cell transplantation. This repair allowed for the patient to successfully become pregnant and carry to term. Additional repairs following bone marrow stem cell transplant to the endometrium include increased vascularity and iron levels, with egg implantation clustering around areas with high blood flow.
Persistent viruses Using quantitative polymerase chain reaction (qPCR) and next-generation sequencing (NGS) a maximum of five DNA viruses per individual have been identified. Included were several herpesviruses, hepatitis B virus, Merkel cell polyomavirus, and human papillomavirus 31. Given the reactivation and/or oncogenic potential of these viruses, their repercussion on hematopoietic and malignant disorders calls for further studies. ==Fossil record==